Dysregulation of Tfeb expression, nuclear localization and transcriptional activity has been observed in various NDDs, including Alzheimer’s Disease, Parkinson’s disease and Huntington’s disease [81]. The gene discussed is TFEB; the disease is Alzheimer disease.